Navigation Links
USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
Date:1/29/2008

Eliminates the Need for Translation of Compendia Used to Ensure the Quality of Pharmaceutical and Over-the-Counter Medications

ROCKVILLE, Md., Jan. 29 /PRNewswire-USNewswire/ -- The U.S. Pharmacopeia is pleased to announce that the third annual Spanish edition of its core compendia, the United States Pharmacopeia and National Formulary (USP-NF), is now available for purchase. The official edition for 2008, USP 31-NF 26, provides specifications needed to produce more than 4,000 quality pharmaceuticals, excipients, dietary supplements, biologics and other therapeutics.

USP-NF, recognized by U.S. federal law as the country's official compendia for drug standards, offers access to monographs defining the required standards for the identity, quality, purity, strength, labeling and packaging for pharmaceutical and over-the-counter medications, dietary supplements, and other health care products. These standards are enforceable by the U.S. Food and Drug Administration for drugs marketed in or exported to the United States, and are also recognized by governments and regulatory agencies throughout the world.

"USP is proud to offer a Spanish edition of the USP-NF for the third year in a row," said Darrell Abernethy, M.D., Ph.D., chief science officer of USP. "By translating the compendia, we hope to better meet the needs of our Spanish-speaking partners as we work together to advance USP's mission of providing good pharmaceutical care for all people, all over the world."

The Spanish edition is an official, expert translation of the USP-NF in English. Written in a universal, neutral Spanish, the translation process is supervised by USP's Spanish Advisory Panel -- a dedicated body of leading scientific experts from Spanish-speaking countries. USP offers expert scientific and technical support in Spanish during business hours that are convenient for Spanish-speaking customers.

USP-NF is used by quality assurance and quality control scientists, pharmaceutical manufacturers, regulatory professionals, compounding professionals, lawyers, and pharmacy and medical schools all over the world. In addition to monograph standards, USP 31-NF 26 provides more than 200 general chapters covering general tests and assays, and information on emerging areas of science and medicine.

To order Farmacopea de los Estados Unidos de America-Formulario National, please contact USP's Customer Service at 1-800-227-8772 or 00-800-4875-5555. For media inquiries, please contact mediarelations@usp.org.


'/>"/>
SOURCE U.S. Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
2. American College of Physicians publishes The Fenway Guide to LGBT Health
3. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
4. Multiple Sclerosis Association of America Publishes Booklet about Depression in Multiple Sclerosis
5. American College of Physicians publishes "Peripheral Arterial Disease"
6. Thomson Scientific Publishes Who Is Making The Biggest Splash? - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007
7. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
8. The Endocrine Society Publishes White Paper Calling for Greater Minority Participation in Clinical Research
9. Springer publishes La Chirurgia degli Organi de Movimento
10. The Diabetes Educator publishes systematic reviews for diabetes management
11. Latin American adolescents are more likely to become infected with HIV than Spanish
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... announce the ATA 2017 President’s Awards recipients, comprised of organizations and individuals ... delivery. , The ATA 2017 President’s Awards recognize individuals and organizations ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... Excellence specializes in pelvic conditions and has helped many women become pregnant upon ... a combination of office-based and simple outpatient evaluations. We can provide the ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... an agile ecosystem and domain expertise for sponsors and CROs to speed ... trial supply management (RTSM) software platform. Bioclinica AGILE RTSM provides ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor ... I/II HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now ... Invisalign® in Lutz, FL. With the help of this highly-effective, yet convenient ... fewer potential complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 21, 2017 Halo Labs announces the launch ... analysis system called the Horizon at PEGS 2017 in ... new system analyzes sub visible particulate matter in biopharmaceutical ... screening as early as candidate selection and pre-formulation. ... contract research organization Elion Labs for system ...
(Date:4/20/2017)... 20, 2017  Vivify Health, the pioneer and market ... awarded a very significant patent for the advancement of ... care via digital health.  This landmark patent provides the ... further secures Vivify,s position as the leader in remote ... the first company to apply consumer mobile devices, wireless ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
Breaking Medicine Technology: